Skip to content
Clinical Trials – home

DEXAMETHASONE DISODIUM PHOSPHATE: A Comprehensive Guide for Patients

3 / 4
trials open to patients / all trials
2+
Countries

In short

Dexamethasone Disodium Phosphate is a corticosteroid medication being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate its effectiveness in reducing inflammation, improving patient outcomes, and managing symptoms in conditions such as acute lymphoblastic leukemia, cardiac arrest, and heart surgery. This article will explore the ongoing research and potential applications of Dexamethasone Disodium Phosphate in clinical settings.

At a glance

Drug Name
Dexamethasone Disodium Phosphate
Drug Class
Corticosteroid
Administration Route
Intravenous
Conditions Studied
Acute Lymphoblastic Leukemia, Out-of-Hospital Cardiac Arrest, Heart Surgery Patients
Primary Objectives
Evaluate efficacy in reducing mortality, improving survival, shortening hospital stays, reducing organ damage
Dosage Range
10-20 mg daily, up to 300 mg total (varies by trial)
Treatment Duration
1-30 days (varies by trial)
Key Endpoints
Mortality rates, days alive outside hospital, minimal residual disease negativity, neurological outcomes
Safety Considerations
Monitoring for adverse events, exclusion of patients with certain pre-existing conditions

What is Dexamethasone Disodium Phosphate?

Dexamethasone Disodium Phosphate is a synthetic form of a naturally occurring hormone called glucocorticoid. It belongs to a class of medications known as corticosteroids. Glucocorticoids are hormones that play a crucial role in regulating various bodily functions, including inflammation, immune response, and metabolism.

Medical Uses

Dexamethasone Disodium Phosphate is used to treat a wide range of medical conditions due to its potent anti-inflammatory and immunosuppressive properties. Some of the conditions it may be used for include:

  • Out-of-hospital cardiac arrest: It is being studied for its potential protective effects in patients who have been resuscitated after a cardiac arrest outside of a hospital setting.
  • Cardiac surgery: Research is ongoing to determine its efficacy in reducing mortality and organ damage in patients undergoing heart surgery, such as coronary artery bypass grafting (CABG) or heart valve replacement.
  • Severe allergic reactions
  • Certain types of cancer
  • Inflammatory conditions such as arthritis
  • Brain swelling

How is it Administered?

Dexamethasone Disodium Phosphate is typically administered as a solution for injection. The most common route of administration is intravenous (IV), which means it is injected directly into a vein. This allows for rapid action and is particularly useful in emergency situations or when immediate effects are needed.

Dosage Information

The dosage of Dexamethasone Disodium Phosphate can vary significantly depending on the condition being treated, the patient's age, weight, and overall health status. In clinical trials, some examples of dosing include:

  • For cardiac arrest patients: Up to 20 mg per day, with a maximum total dose of 60 mg over 3 days.
  • For patients undergoing cardiac surgery: A single dose of up to 20 mg.

It's crucial to note that dosage should always be determined by a healthcare professional, and patients should never adjust their dose without consulting their doctor.

Potential Side Effects

Like all medications, Dexamethasone Disodium Phosphate can cause side effects. Some potential side effects include:

  • Increased blood sugar levels
  • Fluid retention
  • Increased risk of infections
  • Changes in mood or behavior
  • Stomach irritation
  • Changes in blood pressure

It's important to discuss any side effects with your healthcare provider.

Precautions and Contraindications

Dexamethasone Disodium Phosphate may not be suitable for everyone. Some precautions and contraindications include:

  • Pregnancy or breastfeeding
  • Active infections
  • Certain fungal infections
  • Known allergy to dexamethasone or any of its components
  • Certain heart conditions

Always inform your healthcare provider about your complete medical history and any medications you're taking before starting treatment with Dexamethasone Disodium Phosphate.

Ongoing Research

Dexamethasone Disodium Phosphate is currently being studied in several clinical trials to explore its potential benefits in various medical conditions:

  • DANOHCA study: This trial is investigating the use of dexamethasone in patients who have been resuscitated from out-of-hospital cardiac arrest. Researchers are looking at its potential to improve survival rates and neurological outcomes.
  • GLORIOUS II study: This research is examining the effects of dexamethasone in patients undergoing cardiac surgery. The study aims to determine if dexamethasone can reduce mortality, organ damage, and shorten hospital stays for these patients.

These ongoing studies may provide valuable insights into new potential uses for Dexamethasone Disodium Phosphate and help improve patient outcomes in various medical scenarios.

Questions people often ask

Conditions where Dexamethasone Disodium Phosphate is being studied

Each condition opens its own overview and trial list

Trials with Dexamethasone Disodium Phosphate

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).